As per MRFR analysis, the Japan Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 70.4 (USD Million) in 2023. The Japan Extracorporeal Membrane Oxygenation Machine Market Industry is expected to grow from 74.4(USD Million) in 2024 to 130 (USD Million) by 2035. The Japan Extracorporeal Membrane Oxygenation Machine Market CAGR (growth rate) is expected to be around 5.204% during the forecast period (2025 - 2035).
The Japan Extracorporeal Membrane Oxygenation (ECMO) Machine Market is experiencing important trends driven by the increasing prevalence of respiratory diseases and cardiac disorders. The aging population in Japan is significantly contributing to a higher demand for advanced medical technologies, such as ECMO machines, as older individuals often face severe health complications that require mechanical support. Moreover, the COVID-19 pandemic has heightened awareness and investment in critical care technologies, which has propelled the adoption of ECMO machines in hospitals across Japan, creating an urgent need for effective treatment options in critical conditions.
Technological innovation is a potential opportunity in this market, with a concentration on the development of ECMO devices that are both user-friendly and portable, and can be used in both hospital and pre-hospital settings. Japan places a significant emphasis on the advancement of healthcare innovations, and manufacturers are encouraged to investigate advancements such as miniaturisation and integration with telemedicine in order to improve patient care. Furthermore, the market's growth potential can be enhanced by enhanced training programs for healthcare professionals and collaborations with academic institutions, which can result in superior ECMO application outcomes.
Recently, there has been a focus on minimising the risks associated with ECMO procedures, which has resulted in trends that are designed to improve the safety and efficacy of the procedure. In order to mitigate complications, hospitals in Japan are increasingly investing in simulation training and procedure protocols. Additionally, there is an increasing emphasis on data monitoring and analytics in ECMO administration, which enables the development of more personalised patient treatment plans and the more effective utilisation of resources. In general, the Japanese ECMO machine market is experiencing growth, which is being fuelled by the development of patient requirements, healthcare policies, and technological advancements that are specifically designed to enhance critical care services.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Japan's healthcare sector is increasingly focused on addressing the growing prevalence of respiratory and cardiac diseases, which is a major driver for the Japan Extracorporeal Membrane Oxygenation Machine Market Industry. According to the Ministry of Health, Labour and Welfare, Japan recorded approximately 1.8 million hospitalizations due to cardiovascular diseases in the last year. The rise in cases necessitates advanced medical technologies, including Extracorporeal Membrane Oxygenation (ECMO) machines, to provide life-saving support for patients.Furthermore, the Japanese Circulation Society reports that the mortality rate from cardiac diseases is one of the highest globally, prompting urgent investments in ECMO technology for critical care units in hospitals to manage these conditions effectively. As hospitals strive to enhance their critical care capabilities, the demand for ECMO machines is expected to grow significantly.
The Japan Extracorporeal Membrane Oxygenation Machine Market Industry is being propelled forward by significant technological advancements in medical equipment. Innovations in ECMO machines, such as improved biocompatible materials for membranes and enhanced pump systems, are leading to better patient outcomes. The Japanese government actively promotes Research and Development (R&D) initiatives in medical technology, evidenced by the Japan Agency for Medical Research and Development's funding of over 200 billion Yen in 2022 to support innovative technologies in healthcare.As hospitals implement these state-of-the-art ECMO systems, the demand for advanced machinery is expected to further drive market growth.
The demographic shift in Japan towards an aging population is a crucial driver for the Japan Extracorporeal Membrane Oxygenation Machine Market Industry. According to the Ministry of Internal Affairs and Communications, by 2025, approximately 28% of Japan's population will be aged 65 years and older. This age group is particularly susceptible to heart and respiratory conditions, thus increasing the need for ECMO. With a growing elderly population projected to continue over the next decade, healthcare facilities are compelled to enhance their services, which will include the adoption and integration of ECMO machines into their emergency and critical care protocols.
Government support through policy initiatives plays a significant role in driving the Japan Extracorporeal Membrane Oxygenation Machine Market Industry. The Japanese government has invested heavily in healthcare infrastructure and advanced medical technologies, often highlighting the importance of life-saving equipment like ECMO in national health policies. Based on the Health Ministry's strategic plans, funding for critical care technologies has increased by 15% over the last three years.This commitment not only ensures the availability of ECMO machines in hospitals but also encourages manufacturers to invest in production and technology, thereby stimulating the overall market growth in Japan.
The Japan Extracorporeal Membrane Oxygenation Machine Market, particularly focused on the Application segment, showcases a diverse landscape driven by critical healthcare needs. This segment plays a vital role in addressing various life-threatening conditions, thereby providing substantial support to healthcare professionals in acute medical scenarios. Among its various areas, Cardiac Support is essential, particularly in addressing severe cardiac conditions or during surgical interventions. Its importance is amplified in Japan, where the aging population faces a higher prevalence of cardiovascular diseases.
Respiratory Support is another significant area, especially pertinent to patients with severe respiratory failure or conditions such as Acute Respiratory Distress Syndrome (ARDS), which has gained attention in recent years due to health crises. The capability of Extracorporeal Membrane Oxygenation machines to offer vital support during these scenarios significantly impacts patient outcomes. Lastly, Cardiopulmonary Bypass represents a critical function ensuring oxygenation and circulation during major cardiac surgeries.
Given Japan's advanced healthcare infrastructure and technological prowess, the importance of this segment cannot be understated.Continuous advancements in this segment not only enhance the quality of care but also align with Japan's national health objectives to improve healthcare delivery systems, ensuring better outcomes for patients. These Applications collectively highlight the indispensable role of Extracorporeal Membrane Oxygenation machines in modern medicine, underscoring their value within society and the healthcare industry.
The market growth is further fueled by ongoing Research and Development initiatives and a growing awareness of these life-supporting technologies' potential capabilities, setting a foundation for future innovations and improved health outcomes in the region.The Japan Extracorporeal Membrane Oxygenation Machine Market segmentation around these Applications reflects not just the current healthcare landscape but also the evolving needs and technological advancements that define the industry's future trajectory.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Japan Extracorporeal Membrane Oxygenation Machine Market is primarily driven by a diverse range of End Users, with Hospitals playing a crucial role due to their advanced medical infrastructure and the high demand for critical care services. As key healthcare providers, hospitals significantly contribute to the adoption of sophisticated technologies such as Extracorporeal Membrane Oxygenation Machines, catering to patients with severe respiratory and cardiac issues. Ambulatory Surgical Centers also represent a growing segment, emphasizing the need for efficient and portable medical devices that can facilitate outpatient procedures with enhanced safety.
Meanwhile, Home Care Settings are emerging as a vital component of this market, driven by the increasing trend towards personalized healthcare and rehabilitation. The growing aging population in Japan and the rise in chronic diseases further bolster the importance of these settings, as more patients seek treatment in the comfort of their homes. Overall, the distinct characteristics and requirements of these End Users highlight the Japan Extracorporeal Membrane Oxygenation Machine Market's segmentation dynamics, offering unique opportunities and challenges in addressing varying patient needs and healthcare practices.
The Japan Extracorporeal Membrane Oxygenation Machine Market is categorized by various Product Types, including Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO, each playing a critical role in patient management in intensive care units. Venoarterial ECMO, which is primarily used for patients with severe cardiac and respiratory failure, has been gaining traction due to its effectiveness in providing immediate life support. Venovenous ECMO is significant for patients suffering from severe respiratory failure, especially in conditions like COVID-19, where lung function is compromised.
This type ensures oxygenation while reducing the risk of cardiac complications. Arteriovenous ECMO, although less common, is utilized in specific patient populations, highlighting its importance in a niche area for those requiring renal support in conjunction with respiratory assistance. The growing emphasis on advanced cardiac care and increasing incidences of acute respiratory distress syndrome and cardiac-related health issues in Japan showcase a growing demand for these ECMO types, driving innovation and development within the segment. As a result, advancements in technology and increased hospital investments in ECMO setups are likely to enhance service delivery in critical care, ultimately influencing patient outcomes positively.
The Component segment of the Japan Extracorporeal Membrane Oxygenation Machine Market plays a pivotal role in the overall functionality and effectiveness of ECMO systems used in critical care settings. Membrane Oxygenators are essential for providing oxygen and removing carbon dioxide from the blood, which is crucial for patients with severe respiratory or cardiac issues. This component significantly enhances the ability to manage critical conditions while ensuring adequate oxygenation. Blood Pumps are also crucial as they provide the required blood flow during ECMO procedures, influencing the system's efficacy and the patient's recovery process.
These pumps must ensure consistent performance, highlighting their importance in maintaining patient stability. Heat Exchangers assist in maintaining the patient's temperature during therapy, ensuring that hypothermia or hyperthermia does not affect recovery. As Japan continues to invest in advanced healthcare technologies and strive for improved outcomes in intensive care, the demand for these components will likely see considerable growth. This demand reflects broader trends in the healthcare sector, where the need for lifesaving treatments in emergency situations drives innovation and investment in medical technology.
The competitive landscape of the Japan Extracorporeal Membrane Oxygenation Machine Market is dynamic and characterized by a range of key players with innovative technologies and comprehensive product portfolios. The market has witnessed significant growth driven by rising incidences of respiratory and cardiac conditions requiring advanced life support systems. This demand has led manufacturers to invest in research and development to enhance the efficiency and safety of ECMO machines, thereby increasing competition. The presence of established medical device companies along with emerging players has contributed to a robust ecosystem, where collaborations, partnerships, and technological advancements play a crucial role in shaping market dynamics.
The regulatory environment in Japan, focusing on stringent quality and safety standards, has created both challenges and opportunities for companies striving to establish a strong foothold in this specialized segment.Within this competitive framework, Ethicon stands out for its commitment to innovation and quality in the Japan Extracorporeal Membrane Oxygenation Machine Market. The company has leveraged its extensive expertise in medical technologies to deliver advanced solutions tailored to the needs of healthcare providers. Ethicon's strengths lie in its robust product offerings that emphasize reliability and performance, thereby establishing trust among clinicians and medical facilities. The company has built a strong sales and distribution network in Japan, facilitating effective reach to key customers and ensuring that its ECMO machines are readily available in critical healthcare settings.
Furthermore, Ethicon’s focus on collaborating with healthcare professionals to understand market needs has allowed it to continuously refine its product offerings, keeping them aligned with local requirements and standards.LivaNova also plays a pivotal role in the Japan Extracorporeal Membrane Oxygenation Machine Market, renowned for its advanced medical technologies that cater to both cardiac and respiratory care. The company offers a varied portfolio of ECMO products and services that are designed to enhance patient outcomes and operational efficiency in hospitals. LivaNova's strength in the market stems from its dedication to innovation and continuous improvement, leading to the development of state-of-the-art ECMO systems that integrate seamlessly with hospitals' existing infrastructures.
The company has established strong relationships with several key stakeholders in Japan, enabling it to maintain a significant market presence. Additionally, LivaNova has pursued strategic mergers and acquisitions, enhancing its capabilities and expanding its reach in the region. This strategic approach not only boosts its competitive edge but also positions LivaNova as a leading provider in the evolving landscape of extramural medical devices in Japan.
The Japan Extracorporeal Membrane Oxygenation (ECMO) Machine Market is witnessing significant developments as the country continues to enhance its healthcare infrastructure. Recent advancements focus on the introduction of innovative ECMO technologies by major companies such as LivaNova and Terumo Corporation, which aim to improve patient outcomes. Additionally, growth in the Japanese biomedical sector, driven by aging demographics, is catalyzing increased investment in ECMO systems. In June 2023, Boston Scientific announced its collaboration with various Japanese hospitals to expand its ECMO service network, while in August 2023, Medtronic showcased its latest developments in ECMO machine technology at a national healthcare conference. Notably, there have been no reported mergers or acquisitions within this market segment among the key players like Ethicon and Cardinal Health in the last few months, indicating a stable competitive landscape. Furthermore, Japan's Ministry of Health, Labour and Welfare has reported a steady rise in ECMO machine usage, particularly during respiratory illnesses, reflecting the critical role of these devices in acute care settings. Overall, the ECMO market in Japan is poised for growth, spurred by technological advancements and an evolving patient care landscape.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 70.4(USD Million) |
| MARKET SIZE 2024 | 74.4(USD Million) |
| MARKET SIZE 2035 | 130.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.204% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Ethicon, LivaNova, Boston Scientific, Medtronic, Vyaire Medical, Terumo Corporation, Fujifilm Holdings Corporation, Masimo Corporation, Cardinal Health, Sysmex Corporation, Baxter International, Nipro Corporation, Abbott Laboratories, Getinge AB, Asahi Kasei Corporation |
| SEGMENTS COVERED | Application, End User, Product Type, Component |
| KEY MARKET OPPORTUNITIES | Increasing geriatric population, Rising prevalence of respiratory diseases, Technological advancements in ECMO, Growing healthcare infrastructure investment, Expanding regional healthcare access |
| KEY MARKET DYNAMICS | Aging population, High disease prevalence, Increasing healthcare expenditure, Technological advancements, Rising demand for advanced respiratory support |
| COUNTRIES COVERED | Japan |
Frequently Asked Questions (FAQ) :
The Japan Extracorporeal Membrane Oxygenation Machine Market is expected to be valued at 74.4 million USD in 2024.
By 2035, the Japan Extracorporeal Membrane Oxygenation Machine Market is projected to reach a value of 130.0 million USD.
The expected CAGR for the Japan Extracorporeal Membrane Oxygenation Machine Market from 2025 to 2035 is 5.204%.
As of 2024, the Respiratory Support application segment is the largest, valued at 30.0 million USD.
The Cardiac Support application segment is expected to grow to 45.0 million USD by 2035.
The Cardiopulmonary Bypass application segment is valued at 19.4 million USD in 2024.
Key players include Ethicon, LivaNova, Boston Scientific, and Medtronic among others.
Emerging trends in cardiac and respiratory support applications present significant growth opportunities in the market.
Challenges include regulatory hurdles and the need for technological advancements.
Regional factors, including healthcare infrastructure and patient demographics, play a crucial role in market dynamics.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
